Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Cancer Molecular Markers

Circulating Tumor Cells

Translational to Clinical R&D

Technology-Driven Oncology Clinical Development

Predictive Preclinical Models in Oncology


You may also be interested in:


Circulating Cell-Free DNA

Clinical Cancer Immunotherapy

Short Courses:

Translating CTCs to Clinical Use

Regulatory Compliance in Molecular Diagnostics

Isolation and Characterization of Cancer Stem Cells

Using Preclinical Models in Oncology

Best Practices in Personalized and Translational Medicine


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2015 MMTC Final Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems 



Silicon Biosystems 



Thomson Reuters-Large 

Local Partners:




City of SSF